| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 91351 |
DOTA-(t-butyl)3-PEG5-azide(大环化合物) |
161 |
zcy |
2024-11-28 |
| 91352 |
Tm-Maleimido-DOTA cas1552305-24-4 双功能螯合剂 |
142 |
zyl |
2024-11-28 |
| 91353 |
DOTA-tris(OPp酯)缀合物 , DOTA-tris(tBuester) |
159 |
kx |
2024-11-28 |
| 91354 |
4-乙氧羰基-1,7-二氢-1-取代苯基-5-(未)取代吡唑啉[5,1-d][1,2,3,5]四嗪-7-酮衍生物 |
151 |
WYQ |
2024-11-28 |
| 91355 |
1-取代-3-芳基-6-甲基-1,6-二氢-1,2,4,5-四嗪中N1位亚甲基(CH2) |
154 |
WYQ |
2024-11-28 |
| 91356 |
DOTA-AMBF3-PEG2-LLP2A;DOTA偶联跨膜蛋白极晚期抗原4 (VLA-4)的肽LLP2A |
217 |
wyh |
2024-11-28 |
| 91357 |
1-烷基-3-苯基-6-甲基-1,6-二氢-1,2,4,5-四嗪构象研究 |
158 |
WYQ |
2024-11-28 |
| 91358 |
DOTA-MUT-DS ,环状2-螺旋小蛋白偶联大环DOTA |
191 |
kx |
2024-11-28 |
| 91359 |
cas:2353410-19-0 Bromoacetamido-PEG5-DOTA 溴乙酰氨基-五聚乙二醇-DOTA |
212 |
zcy |
2024-11-28 |
| 91360 |
DOTA单酰胺螯合物偶联CLT1肽 , CLT1-dL-(Gd-DOTA) |
186 |
kx |
2024-11-28 |
| 91361 |
3-芳基-6-甲基-1,6-二氢-1,2,4,5-四嗪-1-烷基酮 |
127 |
WYQ |
2024-11-28 |
| 91362 |
3-芳基-6-甲基-1,6-二氢-1,2,4,5-四嗪-1-甲酸酯 |
143 |
WYQ |
2024-11-28 |
| 91363 |
DOTA修饰的声敏脂质体(GdSL ) , DOTA-GdSL |
215 |
kx |
2024-11-28 |
| 91364 |
1189194-65-7,DOTA-CH2-Alkynyl (TFA salt) |
148 |
zcy |
2024-11-28 |
| 91365 |
N-取代苯基-3-芳基-6-甲基-1,6-二氢-1,2,4,5-四嗪-1-甲酰胺 |
154 |
WYQ |
2024-11-28 |
| 91366 |
1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸的酯化前体(DOTA18) |
144 |
kx |
2024-11-28 |
| 91367 |
1610950-41-8,DOTA-甲基四嗪 |
145 |
zcy |
2024-11-28 |
| 91368 |
204318-14-9,Edotreotide,奥曲肽的多肽,DOTA大环化合物 |
135 |
zcy |
2024-11-28 |
| 91369 |
DOTA缀合的9聚体高亲和力uPAR结合肽 , DOTA-AE105 |
182 |
kx |
2024-11-28 |
| 91370 |
环糊精金属有机框架/海藻酸钙复合材料 γ-CD-MOF-SH/CA |
170 |
h |
2024-11-28 |
| 91371 |
四氮杂环十二烷四乙酸-琥珀酰亚胺酯 |
197 |
zyl |
2024-11-28 |
| 91372 |
β环糊精改性聚甲基丙烯酸甲酯-机金属骨架ZIF8 βCD/ZIF8/PMMA |
148 |
h |
2024-11-28 |
| 91373 |
G5-(Gd-DOTA)(96) ,DOTA-钆(Gd)的大分子造影剂 |
226 |
kx |
2024-11-28 |
| 91374 |
β-CD@Cu-MOF纳米复合材料 |
199 |
h |
2024-11-28 |
| 91375 |
DOTA修饰的声敏脂质体 , DOTA-DPPE脂质 |
175 |
kx |
2024-11-28 |
| 91376 |
DOTA(0)-Phe(1)-Tyr(3)-奥曲肽 , 68 Ga-DOTATOC |
132 |
kx |
2024-11-28 |
| 91377 |
1-酰基-3-芳基-6-甲基-1,6-二氢-1,2,4,5-四嗪 |
145 |
WYQ |
2024-11-28 |
| 91378 |
3-芳基-6-烷基-1,6-二氢-1,2,4,5-四嗪 |
210 |
WYQ |
2024-11-28 |
| 91379 |
3,6-二烷基-1,6-二氢-1,2,4,5-四嗪 |
167 |
WYQ |
2024-11-28 |
| 91380 |
3-芳基-6-烷基-1,6-二氢-1,2,4,5-四嗪 |
142 |
WYQ |
2024-11-28 |
| 91381 |
1,6-二氢-1,2,4,5-四嗪 |
213 |
WYQ |
2024-11-28 |
| 91382 |
β-环糊精基金属有机框架 β-CD-MOF |
261 |
h |
2024-11-28 |
| 91383 |
DBCO-PEG(4)-Lys-DOTA , 螯合剂DOTA共轭应变环辛烯衍生物二苄基环辛烯 |
132 |
kx |
2024-11-28 |
| 91384 |
DOTA-Anti-CTLA-4mAbEnabled ;DOTA-抗CTLA-4单克隆抗体 |
154 |
wyh |
2024-11-28 |
| 91385 |
3-芳基-6-烷基-1,2,4,5-四嗪 |
134 |
WYQ |
2024-11-28 |
| 91386 |
3,6-二取代苄基-1,2,4,5-四嗪 |
156 |
WYQ |
2024-11-28 |
| 91387 |
(67)Ga-DOTA-(Asp)14 |
162 |
kx |
2024-11-28 |
| 91388 |
3-芳基-6-取代苄基-1,2,4,5-四嗪 |
159 |
WYQ |
2024-11-28 |
| 91389 |
DOTA-CCMSH ; DOTA缀合的α-MSH类似物 |
140 |
wyh |
2024-11-28 |
| 91390 |
交联环糊精金属有机骨架负载甲氨蝶呤缓释微粒 MTX@COF-CD |
179 |
h |
2024-11-28 |
| 91391 |
DOTA-[Tyr3]-Octreotide 奥曲肽PET探针前体 |
134 |
zcy |
2024-11-28 |
| 91392 |
负载钆(1,4,7,10-四氮杂环十二烷)-1,4,7,10-四乙酸盐(Gd-DOTA) |
300 |
kx |
2024-11-28 |
| 91393 |
DOTA-functionalized;DOTA功能化的聚赖氨酸 |
186 |
wyh |
2024-11-28 |
| 91394 |
DO3A-Serotonin |
147 |
zyl |
2024-11-28 |
| 91395 |
3-芳基-6-烷基-1,2,4,5-四嗪 |
148 |
WYQ |
2024-11-28 |